News snapshot: Irwin Naturals, Fireweed Zinc, CULT Food Science, Zynerba Pharmaceuticals, Bridgeline Digital...
Zynerba Pharma Receives FDA Guidance For Phase 3 Trial Of Zygel; Street Sees 75% Upside
Zynerba Pharmaceuticals Presents During NFXF's 2022 Industry Updates | NFXF
Zynerba Discontinues Development Of Cannabidiol Gel In Epileptic Disorders
Zynerba fragile after pivotal failure | Evaluate
Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session -
Do Traders Think Zynerba Pharmaceuticals Inc (ZYNE) Can Turn Around Tuesday?
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights - Zynerba
Zynerba's Stock Forecast for 2021: Is ZYNE a Good Stock to Buy?
ZYNE Stock Price and Chart — NASDAQ:ZYNE — TradingView
Zynerba-Logo-swoosh-artboard - Zynerba
Zynerba Pharmaceuticals, Inc. (ZYNE) Stock Price Today, Quote & News | Seeking Alpha
News - Zynerba
Zynerba Pharmaceuticals | LinkedIn
Zynerba Pharmaceuticals Presents During NFXF's 2022 Industry Updates | NFXF
Zynerba Pharma (@ZynerbaPharma) / Twitter
Zynerba Pharma (@ZynerbaPharma) / Twitter
